vs
Astrana Health, Inc.（ASTH）とSEALED AIR CORP（SEE）の財務データ比較。上の社名をクリックして会社を切り替えられます
SEALED AIR CORPの直近四半期売上が大きい（$1.4B vs $950.5M、Astrana Health, Inc.の約1.5倍）。SEALED AIR CORPの純利益率が高く（3.1% vs 0.7%、差は2.5%）。Astrana Health, Inc.の前年同期比売上増加率が高い（42.9% vs 2.6%）。SEALED AIR CORPの直近四半期フリーキャッシュフローが多い（$257.7M vs $-6.0M）。過去8四半期でAstrana Health, Inc.の売上複合成長率が高い（53.3% vs 2.7%）
アストラナヘルス社は米国に本拠を置く価値基準型医療サービスプロバイダーで、主に米国全土の連邦医療保険対象高齢者層にサービスを提供している。訪問型プライマリケア、慢性疾患管理、ケアコーディネーションを通じ、患者の健康状態改善と不要な医療費削減を目指している。
シールドエア社は、革新的な包装・保護ソリューションを提供するグローバル企業です。緩衝材、食品の安全性と鮮度保持を実現する包装、廃棄物削減に貢献する持続可能な包装システムを中核に、小売、Eコマース、食品飲料、工業製造などの分野にサービスを展開しています。
ASTH vs SEE — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $950.5M | $1.4B |
| 純利益 | $6.6M | $43.8M |
| 粗利率 | — | 28.6% |
| 営業利益率 | 1.9% | 11.4% |
| 純利益率 | 0.7% | 3.1% |
| 売上前年比 | 42.9% | 2.6% |
| 純利益前年比 | 184.4% | 700.0% |
| EPS（希薄化後） | $0.12 | $0.30 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $950.5M | $1.4B | ||
| Q3 25 | $956.0M | $1.3B | ||
| Q2 25 | $654.8M | $1.3B | ||
| Q1 25 | $620.4M | $1.3B | ||
| Q4 24 | $665.2M | $1.4B | ||
| Q3 24 | $478.7M | $1.3B | ||
| Q2 24 | $486.3M | $1.3B | ||
| Q1 24 | $404.4M | $1.3B |
| Q4 25 | $6.6M | $43.8M | ||
| Q3 25 | $373.0K | $255.1M | ||
| Q2 25 | $9.4M | $93.1M | ||
| Q1 25 | $6.7M | $113.5M | ||
| Q4 24 | $-7.8M | $-7.3M | ||
| Q3 24 | $16.1M | $91.7M | ||
| Q2 24 | $19.2M | $98.3M | ||
| Q1 24 | $14.8M | $82.0M |
| Q4 25 | — | 28.6% | ||
| Q3 25 | — | 29.8% | ||
| Q2 25 | — | 30.7% | ||
| Q1 25 | — | 30.9% | ||
| Q4 24 | — | 30.0% | ||
| Q3 24 | — | 30.1% | ||
| Q2 24 | — | 31.2% | ||
| Q1 24 | — | 30.3% |
| Q4 25 | 1.9% | 11.4% | ||
| Q3 25 | 2.0% | 13.8% | ||
| Q2 25 | 3.1% | 15.0% | ||
| Q1 25 | 3.3% | 14.5% | ||
| Q4 24 | 0.1% | 11.7% | ||
| Q3 24 | 5.9% | 13.9% | ||
| Q2 24 | 6.2% | 15.4% | ||
| Q1 24 | 7.5% | 14.0% |
| Q4 25 | 0.7% | 3.1% | ||
| Q3 25 | 0.0% | 19.0% | ||
| Q2 25 | 1.4% | 7.0% | ||
| Q1 25 | 1.1% | 9.0% | ||
| Q4 24 | -1.2% | -0.5% | ||
| Q3 24 | 3.4% | 6.9% | ||
| Q2 24 | 3.9% | 7.4% | ||
| Q1 24 | 3.7% | 6.2% |
| Q4 25 | $0.12 | $0.30 | ||
| Q3 25 | $0.01 | $1.73 | ||
| Q2 25 | $0.19 | $0.63 | ||
| Q1 25 | $0.14 | $0.77 | ||
| Q4 24 | $-0.14 | $-0.05 | ||
| Q3 24 | $0.33 | $0.63 | ||
| Q2 24 | $0.40 | $0.67 | ||
| Q1 24 | $0.31 | $0.56 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $429.5M | $344.0M |
| 総負債低いほど良い | — | $3.3B |
| 株主資本純資産 | $779.3M | $1.2B |
| 総資産 | $2.2B | $7.0B |
| 負債/資本比率低いほどレバレッジが低い | — | 2.65× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $429.5M | $344.0M | ||
| Q3 25 | $463.4M | $282.5M | ||
| Q2 25 | $342.1M | $354.4M | ||
| Q1 25 | $260.9M | $335.2M | ||
| Q4 24 | $290.8M | $371.8M | ||
| Q3 24 | $350.3M | $386.0M | ||
| Q2 24 | $327.7M | $388.6M | ||
| Q1 24 | $337.3M | $352.8M |
| Q4 25 | — | $3.3B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | — | $4.0B | ||
| Q1 25 | — | $4.2B | ||
| Q4 24 | — | $4.2B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | $4.4B | ||
| Q1 24 | — | $4.5B |
| Q4 25 | $779.3M | $1.2B | ||
| Q3 25 | $775.5M | $1.2B | ||
| Q2 25 | $765.5M | $953.1M | ||
| Q1 25 | $745.4M | $797.9M | ||
| Q4 24 | $712.7M | $624.5M | ||
| Q3 24 | $704.6M | $771.2M | ||
| Q2 24 | $678.9M | $650.1M | ||
| Q1 24 | $653.5M | $598.3M |
| Q4 25 | $2.2B | $7.0B | ||
| Q3 25 | $2.2B | $7.1B | ||
| Q2 25 | $1.4B | $7.2B | ||
| Q1 25 | $1.3B | $7.0B | ||
| Q4 24 | $1.4B | $7.0B | ||
| Q3 24 | $1.3B | $7.3B | ||
| Q2 24 | $1.3B | $7.3B | ||
| Q1 24 | $1.2B | $7.2B |
| Q4 25 | — | 2.65× | ||
| Q3 25 | — | 3.34× | ||
| Q2 25 | — | 4.18× | ||
| Q1 25 | — | 5.26× | ||
| Q4 24 | — | 6.72× | ||
| Q3 24 | — | 5.62× | ||
| Q2 24 | — | 6.81× | ||
| Q1 24 | — | 7.49× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-2.9M | $293.6M |
| フリーキャッシュフロー営業CF - 設備投資 | $-6.0M | $257.7M |
| FCFマージンFCF / 売上 | -0.6% | 18.5% |
| 設備投資強度設備投資 / 売上 | 0.3% | 2.6% |
| キャッシュ転換率営業CF / 純利益 | -0.44× | 6.70× |
| 直近12ヶ月FCF直近4四半期 | $104.5M | $458.5M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-2.9M | $293.6M | ||
| Q3 25 | $10.0M | $165.9M | ||
| Q2 25 | $90.9M | $136.6M | ||
| Q1 25 | $16.6M | $31.9M | ||
| Q4 24 | $-10.9M | $244.2M | ||
| Q3 24 | $34.0M | $170.5M | ||
| Q2 24 | $23.2M | $188.2M | ||
| Q1 24 | $6.0M | $125.1M |
| Q4 25 | $-6.0M | $257.7M | ||
| Q3 25 | $7.4M | $119.6M | ||
| Q2 25 | $89.5M | $93.2M | ||
| Q1 25 | $13.6M | $-12.0M | ||
| Q4 24 | $-13.5M | $185.1M | ||
| Q3 24 | $31.7M | $115.2M | ||
| Q2 24 | $20.4M | $129.5M | ||
| Q1 24 | $5.6M | $78.0M |
| Q4 25 | -0.6% | 18.5% | ||
| Q3 25 | 0.8% | 8.9% | ||
| Q2 25 | 13.7% | 7.0% | ||
| Q1 25 | 2.2% | -0.9% | ||
| Q4 24 | -2.0% | 13.6% | ||
| Q3 24 | 6.6% | 8.6% | ||
| Q2 24 | 4.2% | 9.7% | ||
| Q1 24 | 1.4% | 5.9% |
| Q4 25 | 0.3% | 2.6% | ||
| Q3 25 | 0.3% | 3.4% | ||
| Q2 25 | 0.2% | 3.3% | ||
| Q1 25 | 0.5% | 3.5% | ||
| Q4 24 | 0.4% | 4.4% | ||
| Q3 24 | 0.5% | 4.1% | ||
| Q2 24 | 0.6% | 4.4% | ||
| Q1 24 | 0.1% | 3.6% |
| Q4 25 | -0.44× | 6.70× | ||
| Q3 25 | 26.69× | 0.65× | ||
| Q2 25 | 9.65× | 1.47× | ||
| Q1 25 | 2.48× | 0.28× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | 1.86× | ||
| Q2 24 | 1.21× | 1.91× | ||
| Q1 24 | 0.40× | 1.53× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
SEE
| Protective Segment | $1.1B | 78% |
| Other | $292.0M | 21% |
| Pension Plans Defined Benefit | $7.9M | 1% |
